The implementation of GCP in China , a comparison with the ICH and USA interpretation

• In: G19 - Clinical trials in Asia on Tuesday, 4 September 2007, 9:00-12:00
• At: Beijing (China) (2007)
• Type: Presentation
• By: TIAN, Shaolei (CCD, SFDA, Beijing, China)
• Abstract:

  ABSTRACT The presentation will retrospect the implementation of GCP in China in the past ten years and introduce current laws and regulations related to the clinical trial carried out in China. With the emphasis, the feature of Chinese GCP and related regulations will be compared with the FDA and ICH GCP interpretation, mainly including

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login